title: [Ewing/PNET sarcoma family of tumors: towards a new paradigm?].
abstract: Ewing sarcoma family of tumors are mainly aggressive sarcomas of bone and also arising in soft tissues, which share common features: morphological features of basophilic round cell tumors, immunohistochemical features by expression of membrane CD99 protein, and genetic features with a translocation involving EWS and FLI1 in approximately 90% of cases. The discovery of this translocation has made it possible to unify in a single entity several lesions such as PNET, neuropitheliomas, Askin tumors, Ewing sarcomas… Since then, the extensive use of molecular/genetic methods has helped to identify an increasing number of molecular anomalies in unclassified round cell sarcomas, these sarcomas often harboring an atypical morphology and a less frequent CD99 positivity. Besides the rearrangements between the FET family of genes (EWS or FUS) and the wide ETS family of genes (FLI1, ERG, FEV, ETV…), new partner genes are gradually identified: cases with EWS-non ETS partners are extremely rare, but there are more important groups which are CIC-DUX4 and BCOR-CCNB3 translocation-positive sarcomas. These findings raise the problem of the nosological borders of the Ewing/PNET entity and its links with new "Ewing-like" groups of tumors, and raise the therapeutic problems. The forward-looking identification of new round cell sarcomas should enable studies of wider series to try to answer these questions.
authors.affiliation: Département de biopathologie, centre Léon-Bérard, 28, rue Laennec, 69373 Lyon cedex 8, France. Electronic address: caroline.renard@lyon.unicancer.fr.
authors.forename: Caroline
authors.initials: C
authors.lastname: Renard
authors.affiliation: Département de biopathologie, centre Léon-Bérard, 28, rue Laennec, 69373 Lyon cedex 8, France.
authors.forename: Dominique
authors.initials: D
authors.lastname: Ranchère-Vince
mesh_terms: D014408:Biomarkers, Tumor; D001859:Bone Neoplasms / Q000737:chemistry / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000473:pathology*; D003937:Diagnosis, Differential; D018450:Disease Progression; D006801:Humans; D009361:Neoplasm Invasiveness; D018242:Neuroectodermal Tumors, Primitive / Q000737:chemistry / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000473:pathology*; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D012512:Sarcoma, Ewing / Q000737:chemistry / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000473:pathology*; D012983:Soft Tissue Neoplasms / Q000737:chemistry / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology / Q000235:genetics / Q000473:pathology*; D014178:Translocation, Genetic
chemical_list: D014408:Biomarkers, Tumor; D015514:Oncogene Proteins, Fusion
keywords: BCOR-CCNB3; CIC-DUX4; Ewing sarcoma; Ewing-like; PNET; Sarcome d’Ewing